Abstract

When we reviewed chlorhexidine dental gel (Corsodyl - ICI) in the Bulletin¹ we criticised the lack of evidence for its long-term efficacy for the treatment of chronic periodontal disease and suggested that it should not be used for this purpose. Now a chlorhexidine gluconate 0.2% mouthwash ‘Corsodyl’ (ICI) is being promoted as an aid in treatment and prevention of gingivitis, in the management of recurrent aphthous ulceration and oral candidiasis and to promote gingival healing following periodontal surgery.² The pharmacology of this antiseptic was reviewed in a previous article on the gel.¹